Prognostic significance of diabetes mellitus in patients with atrial fibrillationΑndreas S. Papazoglou, George Giannakoulas, Αναστάσιος Κάρτας et al.|Cardiovascular Diabetology|2021Cited by 48
Associations of Atrial Fibrillation Patterns With Mortality and Cardiovascular Events: Implications of the MISOAC-AF TrialAmalia Baroutidou, George Giannakoulas, Athanasios Samaras et al.|Journal of Cardiovascular Pharmacology and Therapeutics|2022Cited by 11
Prognostic implications of thyroid disease in patients with atrial fibrillationGeorge Giannakoulas, Vasiliki Patsiou, Αlexandra Bekiaridou et al.|Heart and Vessels|2023Cited by 10
Prognostic implications of adherence to oral anticoagulants among patients with atrial fibrillation: Insights from MISOAC-AF trialVasiliki Patsiou, George Giannakoulas, Athanasios Samaras et al.|Journal of Cardiology|2022Cited by 10
Renal function and mortality in patients with atrial fibrillationEvangelos Liampas, George Giannakoulas, Αναστάσιος Κάρτας et al.|Journal of Cardiovascular Medicine|2022Cited by 9